Charles River Laboratories International (NYSE:CRL) Given New $190.00 Price Target at Robert W. Baird
Charles River Laboratories International (NYSE:CRL – Free Report) had its price target decreased by Robert W. Baird from $191.00 to $190.00 in a research report released on Friday, Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Several other research analysts have also commented on the company. Argus […]
More Stories
Darden Restaurants (NYSE:DRI) PT Raised to $175.00 at BMO Capital Markets
Darden Restaurants (NYSE:DRI – Free Report) had its target price increased by BMO Capital Markets from $165.00 to $175.00 in...
BTIG Research Raises Darden Restaurants (NYSE:DRI) Price Target to $195.00
Darden Restaurants (NYSE:DRI – Free Report) had its target price increased by BTIG Research from $175.00 to $195.00 in a...
Darden Restaurants (NYSE:DRI) Price Target Raised to $194.00
Darden Restaurants (NYSE:DRI – Free Report) had its price target hoisted by KeyCorp from $170.00 to $194.00 in a research...
3 Essentials For Planning Out Your Retirement
Everyone’s thought about their retirement at some point or another. While everyone wants to look forward to this, it doesn’t...
Preventative Measures to Protect Your Business
Taking a strong step forward can be a powerful image. If you take measures for your business to be considered...
Michael Kelly Buys 93,000 Shares of FINEOS Co. Holdings plc (ASX:FCL) Stock
FINEOS Co. Holdings plc (ASX:FCL – Get Free Report) insider Michael Kelly bought 93,000 shares of the business’s stock in...